Contineum Therapeutics Cash Flow Statement 2022-2024 | CTNM

Fifteen years of historical annual cash flow statements for Contineum Therapeutics (CTNM).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
20232022
$22.72$-24.25
$0.00$0.48
$-2.34$4.92
$-2.35$5.40
$0$0
$0$0
$0$-0.23
$-2.62$-1.34
$-1.02$-1.27
$19.35$-20.12
$-0.41$-0.12
$0$0
$0$0
$-65.15$22.42
$0$0
$-65.15$22.42
$0$0
$-65.57$22.30
$-3.75$-1.25
$0$0
$-3.75$-1.25
$0.13$0.01
$60.27$0.01
$0$0
$-0.34$0
$56.18$-1.24
$9.96$0.94
$2.22$1.93
$0$0